Eqis Capital Management, Inc. Pfizer Inc Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

A detailed history of Eqis Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 18,945 shares of PFE stock, worth $503,179. This represents 0.05% of its overall portfolio holdings.

Number of Shares

18,945

Previous 20,423 7.24%

Holding current value

$503,179

Previous $571,000 4.03%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $40,940 - $46,394	-1,478 Reduced 7.24%	18,945 $548,000
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $392,060 - $459,421	-15,521 Reduced 43.18%	20,423 $571,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $13,203 - $15,162	-510 Reduced 1.4%	35,944 $997,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $226,129 - $293,716	-8,654 Reduced 19.19%	36,454 $1.05 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $104,773 - $122,470	-3,265 Reduced 6.75%	45,108 $1.5 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $402,738 - $465,958	-11,150 Reduced 18.73%	48,373 $1.77 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $176,664 - $229,990	4,485 Added 8.15%	59,523 $2.43 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $281,102 - $366,948	-6,733 Reduced 10.9%	55,038 $2.82 Million
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $66,952 - $81,732	-1,530 Reduced 2.42%	61,771 $2.7 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $278,668 - $330,413	5,989 Added 10.45%	63,301 $3.32 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $1.02 Million - $1.26 Million	22,199 Added 63.22%	57,312 $2.97 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $39,667 - $58,800	-960 Reduced 2.66%	35,113 $2.07 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $211,400 - $271,562	-5,386 Reduced 12.99%	36,073 $1.55 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $85,142 - $96,452	-2,371 Reduced 5.41%	41,459 $1.62 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $70,027 - $78,977	2,091 Added 5.01%	43,830 $1.59 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $224,182 - $285,066	6,698 Added 19.11%	41,739 $1.54 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $132,746 - $155,742	-4,181 Reduced 10.66%	35,041 $1.29 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $195,057 - $236,633	-6,476 Reduced 14.17%	39,222 $1.28 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $192,994 - $275,746	7,140 Added 18.52%	45,698 $1.74 Million
Q4 2019 Jan 24, 2020	SELL	$32.92 - $37.36 $361,955 - $410,773	-10,995 Reduced 22.19%	38,558 $1.51 Million
Q3 2019 Nov 05, 2019	SELL	$32.49 - $42.13 $216,708 - $281,007	-6,670 Reduced 11.86%	49,553 $1.78 Million
Q2 2019 Jul 18, 2019	BUY	$36.98 - $41.52 $86,718 - $97,364	2,345 Added 4.35%	56,223 $2.44 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $896,400 - $984,844	-23,904 Reduced 30.73%	53,878 $2.29 Million
Q4 2018 Jan 25, 2019	SELL	$38.47 - $43.86 $493,339 - $562,460	-12,824 Reduced 14.15%	77,782 $3.4 Million
Q3 2018 Oct 17, 2018	SELL	$34.47 - $41.81 $21,578 - $26,173	-626 Reduced 0.69%	90,606 $3.75 Million
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $351,797 - $375,051	-10,667 Reduced 10.47%	91,232 $3.31 Million
Q1 2018 Apr 06, 2018	BUY	$31.91 - $37.02 $1.14 Million - $1.33 Million	35,831 Added 54.23%	101,899 $3.62 Million
Q4 2017 Jan 25, 2018	BUY	$33.26 - $35.29 $90,433 - $95,953	2,719 Added 4.29%	66,068 $2.39 Million
Q3 2017 Oct 03, 2017	BUY	$31.0 - $34.15 $1.96 Million - $2.16 Million	63,349	63,349 $2.26 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account

Eqis Capital Management, Inc. Pfizer Inc Transaction History